Biotech Innovation for Sustainability in Developing Countries-- A Perspective from China
Developing countries such as China and India are catching up both as not only significant players in the production of high-tech products, but also increasingly important contributors to produce ideas and global knowledge. But the rapid increase in R&D spending does not guarantee China to be global innovation leaders in knowledge intensive sectors such as biotech industry. The innovation capacity of Chinas biotechnology industry is still not strong. Given the significant increase on the domestic and international biotech patents and journal papers, the knowledge base in China is still concentrated and depends largely on returnees and international firms. And there are several other obstacles in the way of sustainable innovation in this industry. From the outcome of biotechnology innovation perspective, due to the high price and difficulty of accessibility for the medium-low-income households in China, they still cannot benefit from basic health care biotech medicines. The poor, both rural and urban low income households, can not enjoy the full benefits of the gains of biotechnology innovation. The lagging complementary institutional innovations affect biotechnology innovation from benefiting the poor in China. This paper identifies the pathologies of biotech innovation system for sustainability in China, governance of the system and beyond. A “pathway approach bringing together social, technological and policy dynamics has been adopted. We try to identify coherent solutions to enable biotechnology innovation transition towards social sustainability in developing countries through multiple governance perspectives.
Yantai Chen Adrian Ely
China Institute for Science and Technology Policy (CISTP), Tsinghua University Science and Technology Research Unit (SPRU), University of Sussex
国际会议
北京
英文
1-30
2011-07-01（万方平台首次上网日期，不代表论文的发表时间）